Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Lynrock Lake LP OSS One Stop Systems, Inc. 13G/A 9.8% 2y
Point72 Hong Kong Ltd HUYA HUYA Inc. 13G/A 5.4% 2y
T. Rowe Price Investment Management, Inc. LL LL Flooring Holdings, Inc. 13G/A 0% 2y
ArrowMark Colorado Holdings LLC ZIP Ziprecruiter, Inc. 13G/A 10.08% 2y
Divisadero Street Capital Management, LP GRPN Groupon, Inc. 13G/A 5.2% 2y
Energy Income Partners, LLC WLKP Westlake Chemical Partners LP 13G/A 5.9% 2y
Granahan Investment Management, LLC CSTL Castle Biosciences Inc 13G 8.05% 2y
Anders Hove XFOR X4 Pharmaceuticals, Inc 13G 9.99% 2y
ArrowMark Colorado Holdings LLC ALIT Alight, Inc. / Delaware 13G/A 6.32% 2y
SPURWINK MANAGEMENT LLC GPGI GPGI, Inc. 13G/A 6.8% 2y
Yuansheng International Limited SFWL SHENGFENG DEVELOPMENT Ltd 13G 9.3% 2y
CONTINENTAL GENERAL INSURANCE CO SRAX SRAX, Inc. Class A Common Stock 13G/A 7.7% 2y
GLAZER CAPITAL, LLC PGSS Pegasus Digital Mobility Acquisition Corp. 13G/A 14.82% 2y
P SCHOENFELD ASSET MANAGEMENT LP LUNR Intuitive Machines, Inc. 13G/A 4.9% 2y
Ionic Ventures, LLC INBS Intelligent Bio Solutions Inc. 13G/A 4.9% 2y
EcoR1 Capital, LLC NGM NGM Biopharmaceuticals, Inc. Common Stock 13G/A 2.9% 2y
Casdin Capital, LLC MXCT Maxcyte, Inc. 13G/A 0% 2y
ALLIANCEBERNSTEIN L.P. DY Dycom Industries Inc 13G/A 5.9% 2y
Long Focus Capital Management, LLC CLLS Cellectis S.A. 13G/A 6.3% 2y
ALLIANCEBERNSTEIN L.P. SBH Sally Beauty Holdings, Inc. 13G/A 0.1% 2y
BAKER BROS. ADVISORS LP JBIO Jade Biosciences, Inc. 13G/A 6.1% 2y
Ancient Art, L.P. DESP Despegar.com, Corp. 13G/A 5.4% 2y
Atreides Management, LP RH Rh 13G 6.85% 2y
Pfizer Inc AKRO Akero Therapeutics, Inc. Common Stock 13G/A 4.53% 2y
OnyxPoint Global Management LP ESTE Earthstone Energy Inc. Class A Common Stock 13G/A 0% 2y
AWM Investment Company, Inc. RDCM Radcom Ltd 13G 5.3% 2y
RTW INVESTMENTS, LP GHRS GH Research PLC 13G 6.4% 2y
BAKER BROS. ADVISORS LP NRIX Nurix Therapeutics, Inc. 13G/A 9.99% 2y
FIR TREE CAPITAL MANAGEMENT LP KRNL Kernel Group Holdings, Inc. Class A Ordinary Shares 13G/A 7.27% 2y
COHEN & STEERS, INC. WELL Welltower Inc. 13G/A 7.49% 2y
Nextech V Oncology S.C.S., SICAV-SIF KNTE Kinnate Biopharma Inc. Common Stock 13G/A 0% 2y
Nantahala Capital Management, LLC QURE uniQure N.V. 13G/A 6.6% 2y
GLAZER CAPITAL, LLC CURR Currenc Group Inc. 13G/A 6.13% 2y
RTW INVESTMENTS, LP PMVP PMV Pharmaceuticals, Inc. 13G/A 0% 2y
RIVERNORTH CAPITAL MANAGEMENT, LLC EMAT Evolution Metals & Technologies Corp. 13G 5.49% 2y
ALLIANCEBERNSTEIN L.P. MANH Manhattan Associates Inc 13G/A 5.1% 2y
Point72 Asset Management, L.P. AMLX Amylyx Pharmaceuticals, Inc. 13G/A 4.7% 2y
GENERATION INVESTMENT MANAGEMENT LLP SOPH SOPHiA GENETICS SA 13G/A 10.42% 2y
ALLIANCEBERNSTEIN L.P. VEEV Veeva Systems Inc 13G/A 4.2% 2y
Jacques Frederic Kerrest OKTA Okta, Inc. 13G/A 1.9% 2y
SPRUCE HOUSE INVESTMENT MANAGEMENT LLC W Wayfair Inc. 13G/A 4.5% 2y
Venrock Healthcare Capital Partners III, L.P. FDMT 4D Molecular Therapeutics, Inc. 13G/A 8.9% 2y
M3 Funds, LLC RBKB Rhinebeck Bancorp, Inc. 13G/A 9.51% 2y
Irenic Capital Management LP TBPH Theravance Biopharma, Inc. 13G 5.5% 2y
ALLIANCEBERNSTEIN L.P. SBLK Star Bulk Carriers Corp. 13G/A 6.4% 2y
Prime Link Capital International Limited SFWL SHENGFENG DEVELOPMENT Ltd 13G 7.6% 2y
Kevin P. Reilly, Jr. LAMR Lamar Advertising Co 13G/A 11.6% 2y
ARISTEIA CAPITAL, L.L.C. CUK CARNIVAL PLC 13G/A 8.17% 2y
Yang Lu ANL Adlai Nortye Group Ltd. 13G 17.5% 2y
Amar K. Goel PUBM PubMatic, Inc. 13G/A 10.4% 2y